We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAAS:NASDAQNaaS Technology Inc. Analysis

Data as of 2026-05-26 - not real-time

$2.90

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NaaS Technology Inc. trades around $2.90, just below its 20‑day SMA (2.53) but well under the 200‑day SMA (3.01), signaling short‑term momentum amid a longer‑term downtrend. The RSI sits at 60, and the MACD line is above its signal, both pointing to modest bullish bias, while volume is increasing, suggesting renewed trader interest. However, the stock is extremely volatile (101% 30‑day volatility) and carries a high beta (~1.4), indicating sensitivity to market swings. Fundamentally, the company posts a negative operating margin (-2.2%) and zero profit margin, with a forward PE of 290 and a trailing EPS of -$18.82, reflecting severe earnings weakness. Debt stands at $585 M against $82 M of cash, and the book value per share is negative, underscoring balance‑sheet stress. The DCF‑derived fair value of $45.76 is dramatically higher than the current price, but this discrepancy is driven by unrealistic cash‑flow assumptions given the current loss profile. The recent extraordinary general meeting disclosed no material operational turnaround, leaving the outlook unchanged. With a low price‑to‑sales multiple (0.28) and no dividend, the stock offers little income appeal. Geographic exposure to China adds regulatory and policy uncertainty for EV charging infrastructure. Overall, the technical upside is outweighed by fundamental weakness, high leverage, and elevated risk factors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Increasing trading volume and bullish MACD
  • Price near technical support at $2.00
  • Continued earnings losses and high debt

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Negative operating margins and zero profitability
  • Forward PE of 290 indicating severe overvaluation
  • Elevated regulatory and policy risk in China

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Unsustainable balance sheet with high leverage
  • Persistent negative cash flows and lack of dividend
  • High volatility and beta suggesting unstable price behavior

Key Metrics & Analysis

Financial Health

Revenue Growth-35.30%
P/E Ratio290.0
ROA-23.91%
P/B Ratio-0.2
Op. Cash Flow$532.0K
Free Cash Flow$81.0M

Technical Analysis

TrendNeutral
RSI60.5
Support$2.00
Resistance$3.18
MA 20$2.53
MA 50$2.44
MA 200$3.01
MACDBullish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Fair Value$45.76
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.41
Volatility101.58%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.